Scabies and pediculosis pubis: An update of treatment regimens and general review

Clinical Infectious Diseases

Volumn 44, Issue SUPPL. 3, 2007, Pages

  Leone, Peter A ^a,b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZADIRACHTA INDICA EXTRACT; BENZYL BENZOATE; CARBARIL; CROTAMITON; IVERMECTIN; LINDANE; MALATHION; PERMETHRIN; PETROLATUM; PHENOTHRIN; SULFUR; TEA TREE OIL;

APLASTIC ANEMIA; CLINICAL TRIAL; CONVULSION; DIARRHEA; DRUG FATALITY; EPILUMINESCENCE MICROSCOPY; EVALUATION; FLUORESCENCE; HUMAN; INCIDENCE; PARASITE TRANSMISSION; PREVALENCE; PRIORITY JOURNAL; PRURITUS; PUBIC PEDICULOSIS; RASH; REVIEW; RISK FACTOR; SARCOPTES SCABIEI; SINGLE DRUG DOSE; SYMPTOM;

FEMALE; HUMANS; INSECTICIDES; LICE INFESTATIONS; MALE; SCABIES;

EID: 33947411358     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/511428     Document Type: Review

References (66)

1. Walker GJ, Johnstone PW. Interventions for treating scabies. Cochrane Database Syst Rev 2000; (3):CD000320.
2. Wendel K, Rompalo A. Scabies and pediculosis pubis: an update of treatment regimens and general review. Clin Infect Dis 2002; 35(Suppl 2):S146-51.
3. Mathisen GE. Of mites and men - lessons in scabies for the infectious diseases clinician [editorial; comment]. Clin Infect Dis 1998; 27:646-8.
4. Burkhart CG, Burkhart CN, Burkhart KM. An epidemiologic and therapeutic reassessment of scabies. Cutis 2000; 65:233-40.
5. Mimouni D, Gdalevich M, Mimouni FB, Haviv J, Ashkenazi I. The epidemiologic trends of scabies among Israeli soldiers: a 28-year follow-up. Int J Dermatol 1998; 37:586-7.
6. Christophersen J. The epidemiology of scabies in Denmark, 1900 to 1975. Arch Dermatol 1978; 114:747-50.
7. Kimchi N, Green MS, Stone D. Epidemiologic characteristics of scabies in the Israel Defense Force. Int J Dermatol 1989; 28:180-2.
8. Downs AM, Harvey I, Kennedy CT. The epidemiology of head lice and scabies in the UK. Epidemiol Infect 1999; 122:471-7.
9. Holness DL, DeKoven JG, Nethercott JR. Scabies in chronic health care institutions. Arch Dermatol 1992; 128:1257-60.
10. Alberici F, Pagani L, Ratti G, Viale P. Ivermectin alone or in combination with benzyl benzoate in the treatment of human immunodeficiency virus-associated scabies. Br J Dermatol 2000; 142:969-72.
11. Chosidow O. Scabies and pediculosis. Lancet 2000; 355:819-26.
12. Walton SF, McBroom J, Mathews JD, Kemp DJ, Currie BJ. Crusted scabies: a molecular analysis of Sarcoptes scabiei variety hominis populations from patients with repeated infestations. Clin Infect Dis 1999; 29:1226-30.
13. Kemp DJ, Walton SF, Harumal P, Currie BJ. The scourge of scabies. Biologist (London) 2002; 49:19-24.
14. Hashimoto K, Fujiwara K, Punwaney J, et al. Post-scabetic nodules: a lymphohistiocytic reaction rich in indeterminate cells. J Dermatol 2000; 27:181-94.
15. Currie B, Huffam S, O'Brien D, Walton S. Ivermectin for scabies [letter; comment]. Lancet 1997; 350:1551.
16. Adjei O, Brenya RC. Secondary bacterial infection in Ghanaian patients with scabies. East Afr Med J 1997; 74:729-31.
17. Jarrett P, Snow J. Scabies presenting as a necrotizing vasculitis in the presence of lupus anticoagulant. Br J Dermatol 1998; 139:701-3.
18. Valks R, Buezo GF, Dauden E. Scabies and leukocytoclastic vasculitis in an HIV-seropositive man [letter]. Int J Dermatol 1996; 35:605-6.
19. Dieng MT, Ndiaye B, Ndiaye AM. Scabies complicated by acute glomerulonephritis in children: 114 cases observed in two years in a pediatric service in Dakar [in French], Dakar Med 1998; 43:201-4.
20. Micali G, Lacarrubba F, Lo GG. Scraping versus videodermatoscopy for the diagnosis of scabies: a comparative study [letter]. Acta Derm Venereol 1999; 79:396.
21. Argenziano G, Fabbrocini G, Delfino M. Epiluminescence microscopy: a new approach to in vivo detection of Sarcoptes scabiei. Arch Dermatol 1997; 133:751-3.
22. Arlian LG, Estes SA, Vyszenski-Moher DL. Prevalence of Sarcoptes scabiei in the homes and nursing homes of scabietic patients. J Am Acad Dermatol 1988; 19:806-11.
23. Estes SA, Arlian L. Survival of Sarcoptes scabiei [letter]. J Am Acad Dermatol 1981; 5:343.
24. Arlian LG, Runyan RA, Achar S, Estes SA. Survival and infectivity of Sarcoptes scabiei var. canis and var. hominis. J Am Acad Dermatol 1984; 11:210-5.
25. Ong GP, Bhatia SG. Survival of Sarcoptes scabiei [letter]. J Am Acad Dermatol 1982; 6:115-6.
26. Drugstore.com. Available at: http://www.drugstore.com. Accessed 15 August 2006.
27. CVS Pharmacy. Available at: http://www.cvs.com/CVSApp/cvs/gateway/ cvsmain. Accessed 15 August 2006.
28. Kerr Drug. Available at: http://www.Kerrdrug.com. Accessed 15 August 2006.
29. Drug topics red book 1999. Montvale, NJ: Medical Economics, 1999.
30. GetCanadianDrugs.com. Available at: http://www.getcanadiandrugs.com. Accessed 15 August 2006.
31. Usha V, Gopalakrishnan Nair TV. A comparative study of oral ivermectin and topical permethrin cream in the treatment of scabies. J Am Acad Dermatol 2000; 42:236-40.
32. Chouela EN, Abeldano AM, Pellerano G, et al. Equivalent therapeutic efficacy and safety of ivermectin and lindane in the treatment of human scabies. Arch Dermatol 1999; 135:651-5.
33. Madan V, Jaskiran K, Gupta U, Gupta DK. Oral ivermectin in scabies patients: a comparison with 1% topical lindane solution. J Dermatol 2001; 28:481-4.
34. Brooks PA, Grace RF. Ivermectin is better than benzyl benzoate for childhood scabies in developing countries. J Paediatr Child Health 2002; 38:401-4.
35. Brooks PA, Grace RF. Ivermectin is better than benzyl benzoate for childhood scabies in developing countries [comment]. J Paediatr Child Health 2003; 39:392-3.
36. Conti Diaz IA, Amaro J. Treatment of human scabies with oral ivermectin. Rev Inst Med Trop Sao Paulo 1999; 41:259-61.
37. Dourmishev A, Serafimova D, Dourmishev L. Efficacy and tolerance of oral ivermectin in scabies. J Eur Acad Dermatol Venereol 1998; 11:247-51.
38. Elmogy M, Fayed H, Marzok H, Rashad A. Oral ivermectin in the treatment of scabies. Int J Dermatol 1999; 38:926-8.
39. Offidani A, Cellini A, Simonetti O, Fumelli C. Treatment of scabies with ivermectin. Eur J Dermatol 1999; 9:100-1.
40. Huffam SE, Currie BJ. Ivermectin for Sarcoptes scabiei hyperinfestation. Int J Infect Dis 1998; 2:152-4.
41. Yeruham I, Hadani A. Control of human scabies by topical application of ivermectin. Ann Trop Med Parasitol 1998; 92:627-9.
42. Walton SF, Myerscough MR, Currie BJ. Studies in vitro on the relative efficacy of current acaricides for Sarcoptes scabiei var. hominis. Trans R Soc Trop Med Hyg 2000; 94:92-6.
43. Carapetis JR, Connors C, Yarmirr D, Krause V, Currie BJ. Success of a scabies control program in an Australian aboriginal community. Pediatr Infect Dis J 1997; 16:494-9.
44. Bockarie MJ, Alexander ND, Kazura JW, Bockarie F, Griffin L, Alpers MP. Treatment with ivermectin reduces the high prevalence of scabies in a village in Papua New Guinea. Acta Trop 2000; 75:127-30.
45. Dannaoui E, Kiazand A, Piens M, Picot S. Use of ivermectin for the management of scabies in a nursing home. Eur J Dermatol 1999; 9:443-5.
46. Sullivan JR, Watt G, Barker B. Successful use of ivermectin in the treatment of endemic scabies in a nursing home. Australas J Dermatol 1997; 38:137-40.
47. Schultz MW, Gomez M, Hansen RC, et al. Comparative study of 5% permethrin cream and 1% lindane lotion for the treatment of scabies. Arch Dermatol 1990; 126:167-70.
48. Elgart ML. A risk-benefit assessment of agents used in the treatment of scabies. Drug Saf 1996; 14:386-93.
49. Walker GJ, Johnstone PW. Interventions for treating scabies. Cochrane Database Syst Rev 2000; (3):CD000320.
50. Barkwell R, Shields S. Deaths associated with ivermectin treatment of scabies [letter]. Lancet 1997; 349:1144-5.
51. Reintjes R, Hoek C. Deaths associated with ivermectin for scabies [letter; comment]. Lancet 1997; 350:215.
52. Moustafa EH, el Kadi MA, al Zeftawy AH, Singer HM, Khalil KA. The relation between scabies and hypersensitivity to antigens of house dust mites and storage mites. J Egypt Soc Parasitol 1998; 28:777-87.
53. Carslaw RW. Letter: scabies in a spinal injuries ward. Br Med J 1975; 2:617.
54. Estes SA, Estes J. Therapy of scabies: nursing homes, hospitals, and the homeless. Semin Dermatol 1993; 12:26-33.
55. Boix V, Sanchez-Paya J, Portilla J, Merino E. Nosocomial outbreak of scabies clinically resistant to lindane [letter]. Infect Control Hosp Epidemiol 1997; 18:677.
56. Taplin D, Meinking TL, Chen JA, Sanchez R. Comparison of crotamiton 10% cream (Eurax) and permethrin 5% cream (Elimite) for the treatment of scabies in children. Pediatr Dermatol 1990; 7:67-73.
57. Taplin D, Meinking TL, Porcelain SL, Castillero PM, Chen JA. Permethrin 5% dermal cream: a new treatment for scabies. J Am Acad Dermatol 1986; 15:995-1001.
58. Maunder JW. Lice and scabies: myths and reality. Dermatol Clin 1998; 16:843-5, xv.
59. National guideline for the management of P. pubis infestation. Clinical Effectiveness Group (Association of Genitourinary Medicine and the Medical Society for the Study of Venereal Diseases). Sex Transm Infect 1999; 75:S78-9.
60. Meinking TL, Vicaria M, Eyerdam DH, Villar ME, Reyna S, Suarez G. Efficacy of a reduced application time of Ovide lotion (0.5% malathion) compared to Nix creme rinse (1% permethrin) for the treatment of head lice. Pediatr Dermatol 2004; 21:670-4.
61. Hipolito RB, Mallorca FG, Zuniga-Macaraig ZO, Apolinario PC, Wheeler-Sherman J. Head lice infestation: single drug versus combination therapy with one percent permethrin and trimethoprim/sulfamethoxazole. Pediatrics 2001; 107:e30-5.
62. Meinking TL, Clineschmidt CM, Chen C, et al. An observer-blinded study of 1% permethrin creme rinse with and without adjunctive combing in patients with head lice. J Pediatr 2002; 141:665-70.
63. Downs AM, Stafford KA, Harvey I, Coles GC. Evidence for double resistance to permethrin and malathion in head lice. Br J Dermatol 1999; 141:508-11.
64. Pollack RJ, Kiszewski A, Armstrong P, et al. Differential permethrin susceptibility of head lice sampled in the United States and Borneo. Arch Pediatr Adolesc Med 1999; 153:969-73.
65. Picollo MI, Vassena CV, Casadio AA, Massimo J, Zerba EN. Laboratory studies of susceptibility and resistance to insecticides in Pediculus capitis (Anoplura; Pediculidae). J Med Entomol 1998; 35:814-7.
66. Speare R, Koehler JM. A case of pubic lice resistant to pyrethrins. Aust Fam Physician 2001; 30:572-4.